These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Management of polymyositis and dermatomyositis.
    Author: Ansell BM.
    Journal: Clin Rheum Dis; 1984 Apr; 10(1):205-13. PubMed ID: 6734117.
    Abstract:
    The overall prognosis for polymyositis and dermatomyositis has improved with the judicious use of corticosteroids, while azathioprine and other cytotoxic agents are of value in improving functional ability and decreasing the total steroid requirement. However, the duration of therapy and the relative risks of it must be under constant surveillance. Problems such as respiratory or cardiac failure in the course of the disease are of serious importance and require particular care in management . Finally, the possibility of neoplasm underlying the disease or occurring as a sequel to cytotoxic therapy should always be borne in mind.
    [Abstract] [Full Text] [Related] [New Search]